(Il Sole 24 Ore Radiocor) - London, 05 Sep - In European stock market dealings, shares in BioMerieux jumped 4.17% at 107.30 euros after the French provider of in vitro diagnostics increased its full-year guidance. The company said that in the first half organic sales rose 9.9% to 1.902 billion euros.

Contributive operating income before non-recurring items (CEBIT) reached 306 million euros for the first half of the year, up 20% like for like. The margin improved by 155 basis points at constant exchange rates.

AAA-Zap

(RADIOCOR) 05-09-24 18:28:12 (0557) 5 NNNN